NCT04485013 2026-02-18
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Phase 1 Recruiting
Tizona Therapeutics, Inc
Alliance for Clinical Trials in Oncology
Pfizer
C4 Therapeutics, Inc.
GlaxoSmithKline
Rutgers, The State University of New Jersey
Eli Lilly and Company
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano